The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

15 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.EBI
Abbott Laboratories
Lead optimization of antimalarial propafenone analogues.EBI
St. Jude Children'S Research Hospital
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.EBI
Universite De Liege
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.EBI
Abbott Laboratories
Optimization of propafenone analogues as antimalarial leads.EBI
St. Jude Children'S Research Hospital
Virtual screening for novel openers of pancreatic K(ATP) channels.EBI
University Of Perugia
New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells.EBI
Novo Nordisk Research And Development
3-trifluoromethyl-4-nitro-5-arylpyrazoles are novel K(ATP) channel agonists.EBI
Glaxosmithkline
Structure-activity relationship of a novel class of naphthyl amide KATP channel openers.EBI
Abbott Laboratories
Synthesis and evaluation of 7-substituted-3-cyclobutylamino-4H-1,2,4-benzothiadiazine-1,1-dioxide derivatives as K(ATP) channel agonists.EBI
Glaxosmithkline
6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells.EBI
Novo Nordisk Research And Development
Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes: correlation of binding affinities with cardioprotective and smooth muscle relaxing potencies.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.EBI
Abbott Laboratories
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.EBI
Abbott Laboratories